Actively Recruiting
Detecting Alzheimers Disease and Affective Disorders Early Using Automated Voice and Speech Analysis in Adults 50 to 100 Years Old
Led by Centre Hospitalier Universitaire de Nice · Updated on 2026-03-19
100
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating the use of voice and speech patterns to detect early signs of Alzheimers disease and affective disorders. This observational study aims to develop an algorithm that identifies vocal biomarkers linked to Alzheimers dementia by comparing speech data with established biological markers like amyloid 1-42 and p-Tau in cerebrospinal fluid. This approach could reduce the need for invasive procedures such as lumbar punctures and PET scans currently used for diagnosis. Participants will take part in a single semi-automated phone call during which they will complete a series of cognitive tasks. These include verbal learning recall immediate and delayed, story recall, narrative storytelling, and verbal fluency tasks. Each task is recorded in a secondary audio stream to allow detailed analysis of speech and cognitive performance. During the study, participants responses during the phone call are collected and analyzed to build and validate machine learning models for detecting relevant cognitive phenotypes. The main outcome is to assess how well speech patterns can identify early stages of neurocognitive disorders. Participants need only one 20-minute session, and their existing biomarker and neuropsychological data are used. The study runs until October 2027.
CONDITIONS
Brief Title
Early Detection of Alzheimer's Disease and Affective Disorders by Automated Voice and Speech Analysis (PLATA)
Research Team
E
Eric ETTORE, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here